Aspergillus niger: An unusual cause of invasive pulmonary aspergillosis

Journal of Medical Microbiology

Volumn 59, Issue 7, 2010, Pages 834-838

  Person, A K ^a   Chudgar, S M ^a   Norton, B L ^a   Tong, B C ^a   Stout, J E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM OXALATE; STEROID; VORICONAZOLE;

AGED; ARTICLE; ASPERGILLUS NIGER; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG MONITORING; FEMALE; FUNGUS HYPHAE; HEMOPTYSIS; HISTOPATHOLOGY; HUMAN; INVASIVE ASPERGILLOSIS; LOBECTOMY; LUNG ASPERGILLOSIS; LUNG LAVAGE; LUNG PARENCHYMA; PRIORITY JOURNAL; SPUTUM CULTURE; TEMPORAL ARTERITIS; THORAX PAIN; THORAX RADIOGRAPHY; TISSUE CULTURE;

AGED; ANTIFUNGAL AGENTS; ASPERGILLUS NIGER; FEMALE; HUMANS; LUNG; PULMONARY ASPERGILLOSIS; PYRIMIDINES; TRIAZOLES;

EID: 77954514118     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.018309-0     Document Type: Article

References (26)

1. Araiza, J., Canseco, P. & Bonifaz, A. (2006). Otomycosis: clinical and mycological study of 97 cases. Rev Laryngol Otol Rhinol (Bord) 127, 251-254.
2. Araujo, R. & Rodrigues, A. G. (2004). Variability of germinative potential among pathogenic species of Aspergillus. J Clin Microbiol 42, 4335-4337.
3. Baddley, J. W., Marr, K. A., Andes, D. R., Walsh, T. J., Kauffman, C. A., Kontoyiannis, D. P., Ito, J. I., Balajee, S. A., Pappas, P. G. & Moser, S. A. (2009). Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network. J Clin Microbiol 47, 3271-3275.
4. Baron, O., Guillaumé, B., Moreau, P., Germaud, P., Despins, P., De Lajartre, A. Y. & Michaud, J. L. (1998). Aggressive surgical management in localized pulmonary mycotic and nonmycotic infections for neutropenic patients with acute leukemia: report of eighteen cases. J Thorac Cardiovasc Surg 115, 63-69.
5. Bochud, P. Y., Chien, J. W., Marr, K. A., Leisenring, W. M., Upton, A., Janer, M., Rodrigues, S. D., Li, S., Hansen, J. A. & other authors (2008). Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N Engl J Med 359, 1766-1777.
6. Bulpa, P., Dive, A. & Sibille, Y. (2007). Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J 30, 782-800.
7. Danner, B. C., Didilis, V., Dorge, H., Mikroulis, D., Bougioukas, G. & Schondube, F. A. (2008). Surgical treatment of pulmonary aspergillosis/mycosis in immunocompromised patients. Interact Cardiovasc Thorac Surg 7, 771-776.
8. De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., Pappas, P. G., Maertens, J., Lortholary, O. & other authors (2008). Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46, 1813-1821.
9. Desta, Z., Zhao, X., Shin, J. G. & Flockhart, D. A. (2002). Clinical significance of the cytochrome P450 2C19 genetic polymorphism. Clin Pharmacokinet 41, 913-958. (Pubitemid 35168437)
10. Fianchi, L., Picardi, M., Cudillo, L., Corvatta, L., Mele, L., Trape, G., Girmenia, C. & Pagano, L. (2004). Aspergillus niger infection in patients with haematological diseases: a report of eight cases. Mycoses 47, 163-167.
11. Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J. W., Kern, W. V., Marr, K. A., Ribaud, P. & other authors (2002). Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347, 408-415.
12. Johnson, L. B. & Kauffman, C. A. (2003). Voriconazole: a new triazole antifungal agent. Clin Infect Dis 36, 630-637.
13. Kimmerling, E. A., Fedrick, J. A. & Tenholder, M. F. (1992). Invasive Aspergillus niger with fatal pulmonary oxalosis in chronic obstructive pulmonary disease. Chest 101, 870-872.
14. Loudon, K. W., Coke, A. P., Burnie, J. P., Shaw, A. J., Oppenheim, B. A. & Morris, C. Q. (1996). Kitchens as a source of Aspergillus niger infection. J Hosp Infect 32, 191-198.
15. Mehrad, B., Paciocco, G., Martinez, F. J., Ojo, T. C., Iannettoni, M. D. & Lynch, J. P., III (2001). Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature. Chest 119, 169-175.
16. Nakagawa, Y., Shimazu, K., Ebihara, M. & Nakagawa, K. (1999). Aspergillus niger pneumonia with fatal pulmonary oxalosis. J Infect Chemother 5, 97-100.
17. Patterson, T. F., Kirkpatrick, W. R., White, M., Hiemenz, J. W., Wingard, J. R., Dupont, B., Rinaldi, M. G., Stevens, D. A. & Graybill, J. R. for the I3 Aspergillus Study Group (2000). Invasive aspergillosis: disease spectrum, treatment practices, and outcomes. Medicine (Baltimore) 79, 250-260.
18. Perfect, J. R., Cox, G. M., Lee, J. Y., Kauffman, C. A., de Repentigny, L., Chapman, S. W., Morrison, V. A., Pappas, P., Hiemenz, J. W. & Stevens, D. A. (2001). The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 33, 1824-1833.
19. Procop, G. W. & Johnston, W. W. (1997). Diagnostic value of conidia associated with pulmonary oxalosis: evidence of an Aspergillus niger infection. Diagn Cytopathol 17, 292-294.
20. Robinson, L. A., Reed, E. C., Galbraith, T. A., Alonso, A., Moulton, A. L. & Fleming, W. H. (1995). Pulmonary resection for invasive Aspergillus infections in immunocompromised patients. J Thorac Cardiovasc Surg 109, 1182-1197.
21. Salerno, C. T., Ouyang, D. W., Pederson, T. S., Larson, D. M., Shake, J. P., Johnson, E. M. & Maddaus, M. A. (1998). Surgical therapy for pulmonary aspergillosis in immunocompromised patients. Ann Thorac Surg 65, 1415-1419.
22. Smith, J., Safdar, N., Knasinski, V., Simmons, W., Bhavnani, S. M., Ambrose, P. G. & Andes, D. (2006). Voriconazole therapeutic drug monitoring. Antimicrob Agents Chemother 50, 1570-1572.
23. Sutton, D. A., Fothergill, A. W. & Rinaldi, M. G. (editors) (1998). Guide to Clinically Significant Fungi, 1st edn. Baltimore, MD: Williams and Wilkins.
24. Walsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J. & other authors (2008). Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46, 327-360.
25. Wiggins, J., Clark, T. J. & Corrin, B. (1989). Chronic necrotising pneumonia caused by Aspergillus niger. Thorax 44, 440-441. (Pubitemid 19143959)
26. Xavier, M. O., Sales, M. P. U., Camargo, J. J. P., Pasqualotto, A. C. & Severo, L. C. (2008). Aspergillus niger causing tracheobronchitis and invasive pulmonary aspergillosis in a lung transplant recipient: case report. Rev Soc Bras Med Trop 41, 200-201.